Evidence map›Paper›PMID 26171777›Full record

Observational studyPloS one2015

Lack of Effectiveness of Antiretroviral Therapy in Preventing HIV Infection in Serodiscordant Couples in Uganda: An Observational Study.

Josephine Birungi, Jeong Eun Min, Katherine A Muldoon, Pontiano Kaleebu, Rachel King, Sarah Khanakwa, Maureen Nyonyintono, YaLin Chen, Edward J Mills, Fred Lyagoba and 4 more

Abstract readObservational Study
In one paragraph

Observational study in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Risk of sexual transmission of human immunodeficiency virus with antiretroviral therapy, suppressed viral load and condom use: a systematic review.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2018
    Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Observational
  10. Antiretroviral Therapy to Prevent HIV Acquisition in Serodiscordant Couples in a Hyperendemic Community in Rural South Africa.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
    Article
  11. HIV treatment as prevention in men who have sex with men: examining the evidence.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2016
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Josephine BirungiThe AIDS Support Organisation, Kampala, Uganda.
Jeong Eun MinBC Centre for Excellence in HIV/ AIDS, Vancouver, Canada.
Katherine A MuldoonBC Centre for Excellence in HIV/ AIDS, Vancouver, Canada; University of British Columbia, Faculty of Medicine, Vancouver, Canada.
Pontiano KaleebuMedical Research Council (UK)-Uganda Virus Research Institute Research Unit on AIDS, Entebbe, Uganda; London School of Hygiene and Tropical Medicine, London, United Kingdom.
Rachel KingUniversity of California, San Francisco, Kampala, Uganda.
Sarah KhanakwaThe AIDS Support Organisation, Kampala, Uganda.
Maureen NyonyintonoThe AIDS Support Organisation, Kampala, Uganda.
YaLin ChenBC Centre for Excellence in HIV/ AIDS, Vancouver, Canada.
Edward J MillsFaculty of Health Sciences, University of Ottawa, Ottawa, Canada.
Fred LyagobaMedical Research Council (UK)-Uganda Virus Research Institute Research Unit on AIDS, Entebbe, Uganda.
Manon Ragonnet-CroninInstitute of Evolutionary Biology, University of Edinburgh, Edinburgh, United Kingdom.
Jonathan WangisiThe AIDS Support Organisation, Kampala, Uganda.
Lillian LourencoBC Centre for Excellence in HIV/ AIDS, Vancouver, Canada.
David M MooreBC Centre for Excellence in HIV/ AIDS, Vancouver, Canada; University of British Columbia, Faculty of Medicine, Vancouver, Canada.

Funding

CIHRMedical Research Council MC_UP_1204/1
6 · The paper itself

Abstract

backgroundWe examined the real-world effectiveness of ART as an HIV prevention tool among HIV serodiscordant couples in a programmatic setting in a low-income country.

methodsWe enrolled individuals from HIV serodiscordant couples aged ≥18 years of age in Jinja, Uganda from June 2009 - June 2011. In one group of couples the HIV positive partner was receiving ART as they met clinical eligibility criteria (a CD4 cell count ≤250 cells/ μL or WHO Stage III/IV disease). In the second group the infected partner was not yet ART-eligible. We measured HIV incidence by testing the uninfected partner every three months. We conducted genetic linkage studies to determine the source of new infections in seroconverting participants.

resultsA total of 586 couples were enrolled of which 249 (42%) of the HIV positive participants were receiving ART at enrollment, and an additional 99 (17%) initiated ART during the study. The median duration of follow-up was 1.5 years. We found 9 new infections among partners of participants who had been receiving ART for at least three months and 8 new infections in partners of participants who had not received ART or received it for less than three months, for incidence rates of 2.09 per 100 person-years (PYRs) and 2.30 per 100 PYRs, respectively. The incidence rate ratio for ART-use was 0.91 (95% confidence interval 0.31-2.70; p=0.999). The hazard ratio for HIV seroconversion associated with ART-use by the positive partner was 1.07 (95% CI 0.41-2.80). A total of 5/7 (71%) of the transmissions on ART and 6/7 (86%) of those not on ART were genetically linked.

conclusionOverall HIV incidence was low in comparison to previous studies of serodiscordant couples. However, ART-use was not associated with a reduced risk of HIV transmission in this study.

Indexed as

Family CharacteristicsAdultAnti-HIV AgentsCD4 Lymphocyte CountCircumcision, MaleFemaleHerpes GenitalisHerpesvirus 2, HumanHIV InfectionsHumansMaleMiddle AgedUgandaAnti-HIV Agents

Identifiers

PMID26171777
PMCPMC4501729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.